Open AccessDrug-Induced Peripheral Neuropathy: A Narrative Review
Author(s) -
Mark R. Jones,
Ivan Urits,
John E. Wolf,
Devin Corrigan,
Luc Colburn,
Emily Peterson,
Amber Williamson,
Omar Viswanath
Publication year - 2020
Publication title -
current clinical pharmacology
Language(s) - English
Resource type - Journals
eISSN - 2212-3938
pISSN - 1574-8847
DOI - 10.2174/1574884714666190121154813
Subject(s) - medicine , duloxetine , peripheral neuropathy , neuropathic pain , gabapentin , intensive care medicine , adverse effect , drug , pregabalin , diabetes mellitus , pharmacology , anesthesia , alternative medicine , pathology , endocrinology
Peripheral neuropathy is a painful condition deriving from many and varied etiologies. Certain medications have been implicated in the iatrogenic development of Drug Induced Peripheral Neuropathy (DIPN) and include chemotherapeutic agents, antimicrobials, cardiovascular drugs, psychotropic, anticonvulsants, among others. This review synthesizes current clinical concepts regarding the mechanism, common inciting medications, and treatment options for drug-induced peripheral neuropathy.